Coenzyme Q10 (CoQ10, also called ubiquinone because of its ubiquitous distribution in all human tissues) is a quinone compound that is essential for the mitochondrial electron transport chain — it is the electron carrier that shuttles electrons from Complex I and Complex II to Complex III, and it is also a membrane antioxidant that protects the mitochondrial membranes from oxidative damage. CoQ10 is synthesised in the body from the amino acid tyrosine and from the mevalonate pathway (the same pathway that is used for cholesterol synthesis), and it is also obtained from dietary sources including meat, fish, poultry, and the small amounts that are present in fruits and vegetables. CoQ10 is present in every cell in the body, with the highest concentrations in the heart (where it constitutes approximately 0.5% of the total dry weight of the myocardium), in the liver, in the kidneys, and in the skeletal muscles. The clinical importance of CoQ10 is underscored by the observation that the tissue CoQ10 levels decline with age (by approximately 50% between the ages of 20 and 80), and that this decline is associated with the mitochondrial dysfunction that is one of the primary hallmarks of the cellular ageing process.
The Electron Transport Chain and the Q Cycle
The mitochondrial electron transport chain consists of four Complexes (I, II, III, and IV) that are embedded in the inner mitochondrial membrane, and of the ATP synthase (Complex V) that is coupled to the electron transport chain by the proton gradient that is generated by the electron transport process. CoQ10 is the mobile electron carrier that shuttles electrons from Complex I (NADH dehydrogenase) and Complex II (succinate dehydrogenase) to Complex III (cytochrome bc1 complex), transferring two electrons at a time and carrying between two and four protons from the matrix to the intermembrane space in each oxidation-reduction cycle. This CoQ10-dependent electron transfer is the foundation of the mitochondrial electron transport chain, and without CoQ10, the electron transport chain cannot function and ATP synthesis is severely impaired. The CoQ10-dependent electron transfer is also the primary source of the reactive oxygen species (ROS) that are generated by the mitochondria (primarily from the semi-ubiquinone radical that is formed when CoQ10 accepts one electron), and the local antioxidant function of CoQ10 in the mitochondrial membrane is one of the primary mechanisms by which mitochondria protect themselves from the oxidative damage that would otherwise result from this ROS production.
The clinical importance of CoQ10 for mitochondrial function is most dramatically demonstrated by the primary CoQ10 deficiency syndromes — a group of rare genetic disorders that are characterised by very low CoQ10 levels and by a clinical syndrome that includes encephalomyopathy (muscle weakness and cognitive impairment), cerebellar ataxia, retinopathy, renal failure, and in the most severe cases, multi-organ failure. The treatment of primary CoQ10 deficiency involves CoQ10 supplementation at very high doses (up to 3,000mg daily in divided doses, which is approximately 30 times the typical supplemental dose), which restores tissue CoQ10 levels and partially reverses the clinical manifestations in the majority of patients. The dramatic response to CoQ10 in primary CoQ10 deficiency is one of the most powerful demonstrations of the essential role of CoQ10 in human cellular energetics.
CoQ10 and Heart Failure
Heart failure is the clinical condition that has been most extensively studied in relation to CoQ10 supplementation, and the evidence is compelling. In heart failure, the mitochondrial dysfunction that characterises the failing myocardium leads to reduced ATP production, increased oxidative stress, and reduced contractile function. CoQ10 supplementation improves the mitochondrial function of the myocardium, increases the ATP production in the failing heart, reduces oxidative stress, and improves the contractile function of the heart. A meta-analysis of 13 RCTs in patients with heart failure found that CoQ10 supplementation at 100-300mg daily significantly improved the exercise capacity (as measured by the 6-minute walk test), improved the symptoms (NYHA functional class), reduced the hospitalisation rate (by approximately 40%), and reduced all-cause mortality (by approximately 40%) compared to placebo. The 2014 Q-SYMBIO trial (a large RCT in 420 patients with heart failure) confirmed that CoQ10 supplementation at 100mg three times daily (300mg daily) significantly reduced all-cause mortality and hospitalisation for heart failure compared to placebo, establishing CoQ10 as an evidence-based treatment for heart failure.
Practical Application
For general CoQ10 supplementation, the evidence-based dose is 100-300mg of CoQ10 daily (as ubiquinone or ubiquinol, the reduced form, which has better absorption and which is preferred for people over the age of 50 who may have impaired CoQ10 absorption). CoQ10 should be taken with a fat-containing meal because it is a fat-soluble molecule that requires bile acids for optimal absorption. The primary clinical indications for CoQ10 supplementation are heart failure (at 100-300mg daily, which is an evidence-based treatment that is supported by multiple RCTs and by the 2014 Q-SYMBIO trial), statin-induced myopathy (at 100-200mg daily, which reduces the muscle pain and the mitochondrial dysfunction that are associated with statin use), and age-related cognitive decline (at 100-200mg daily, which may support mitochondrial function in neurons and reduce the risk of neurodegeneration). For comprehensive mitochondrial support, CoQ10 pairs well with the omega-3 fatty acids (which support mitochondrial membrane composition and which have independent cardiovascular benefits), with alpha-lipoic acid (which is a broad-spectrum antioxidant that regenerates other antioxidants including CoQ10), with L-carnitine (which supports fatty acid oxidation and mitochondrial energy production), and with the B-complex vitamins (which are required for the function of the mitochondrial enzymes and for the synthesis of CoQ10).
Leave a Reply